Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009719
Filing Date
2022-05-12
Accepted
2022-05-12 16:33:49
Documents
76
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20220331.htm   iXBRL 10-Q 2613774
2 EX-31.1 aura-ex31_1.htm EX-31.1 23217
3 EX-31.2 aura-ex31_2.htm EX-31.2 23173
4 EX-32.1 aura-ex32_1.htm EX-32.1 21509
  Complete submission text file 0000950170-22-009719.txt   8801517

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aura-20220331_cal.xml EX-101.CAL 44615
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aura-20220331.xsd EX-101.SCH 61198
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aura-20220331_lab.xml EX-101.LAB 475884
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aura-20220331_pre.xml EX-101.PRE 355313
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aura-20220331_def.xml EX-101.DEF 233829
70 EXTRACTED XBRL INSTANCE DOCUMENT aura-20220331_htm.xml XML 1480752
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 22918421
SIC: 2836 Biological Products, (No Diagnostic Substances)